Empulse is a new early-access 6v6 arena shooter for Xbox Series X|S, PS5, and PC, from developer 1047 Games, the team behind ...

A researcher found that using Anthropic’s Claude Opus 4.7, he could break into the website of Front Gate—used by every ...

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

This week’s cybersecurity recap covers Firefox and Chrome bugs, EDR-killer tools, a TV botnet, an OpenBSD flaw, Android ...

Microsoft CEO Satya Nadella slammed one of the software giant’s own executives for outlining a plan to “make people addicted” to a new AI tool called “Scout.” The rebuke from Nadella, which was posted ...

Colleges are failing to prepare students for an AI-driven workplace by teaching many of them to treat the technology as cheating, according to Rob Hillard, the CEO of Deloitte's Asia-Pacific branch.

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

The article mentions how symbolic recursion can destabilize identity and it’s how the true self emerges but it’s kinda vague on the details or the how and I just want to know how much of this is true?

Two years ago, an AI tool won Google DeepMind a Nobel. Researchers are now climbing toward a new goal. During Tuesday’s Google I/O keynote, Demis Hassabis, the CEO of Google DeepMind, proclaimed that ...

Shinichi Inoue, VP of Game Development Platform and AI Solutions at Capcom, has revealed during an interview with 4Gamers.net from the Google Cloud Next 2026 in Las Vegas that the Resident Evil ...

With a stock price of $3.32, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 10 Unrivaled Penny Stocks to Buy Now. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) reported first-quarter ...